Recent Blog Posts
View Post: Effects of valsartan on morbidity and mortality in uncontrolled ...
14 Oct 2009 by Sawada, T., Yamada, H., Dahlof, B., Matsubara,...
A total of 3031 Japanese patients (43% female, mean 66 years) with uncontrolled hypertension were randomized to either valsartan add-on or non-ARB treatment. Median follow-up period was 3.27 years. In both groups, blood pressure at ...
View Blog: European Heart Journal - recent issues - http://eurheartj.oxfordjournals.org/
View Post: Approval of Diovan (valsartan) in US for hypertension in children ...
27 Nov 2009 by onlinefauci
Diovan (valsartan), an angiotensin receptor blocker or ARB, has been approved following a priority review by the US Viands and Downer Distribution (FDA) for the benefit of the treatment of high blood intimidation in children and ...
View Blog: Online fauci - http://onlinefauci.higgsino.com/
View Post: the KYOTO HEART Study: Valsartan reduces morbidity and mortality ...
2 Sep 2009 by AntonioCaperna
The KYOTO HEART Study, which took place in Japan between January 2004 and January 2009, shows that the addition of valsartan to conventional antihypertensive treatment to improve blood pressure control is associated with an improved ...
View Blog: SALUTE DOMANI ∞ IL PORTALE DEL BENESSERE - http://www.salutedomani.com/il_weblog_di_antonio/
View Post: Valsartan and aliskiren (Valturna): Combination of an angiotensin ...
31 Oct 2009
By targeting two key points within the RAAS, valsartan-aliskiren helps blood vessels relax and widen thereby lowering blood pressure. Valturna was approved on September 16, 2009, for the treatment of hypertension in patients not ...
View Blog: Modern Medicine - Clinical Pharmacology - http://www.modernmedicine.com/modernmedicine/Clinical+P...
View Post: STAT!Ref Weblog: New Title and Supplemental Updates
21 hours ago by Julie
Aliskiren/Valsartan (Valturna) for Hypertension. Tolvaptan (Samsca) for Hyponatremia. DrugPoints® System. ©2009 Thomson Healthcare, Inc. Authors/Editors: Thomson Healthcare, Inc. Rather than giving you too little or too much information ...
View Blog: STAT!Ref Weblog - http://statref.typepad.com/main/

Not Signed In -

